Invatec has announced the European launch of a new peripheral balloon, the IN.PACT Amphirion paclitaxel-eluting PTA balloon catheter.
Subscribe to our email newsletter
This is the first drug-eluting catheter designed specifically to treat atherosclerosis in arteries located below the knee, the company said.
IN.PACT features FreePac, a proprietary coating that frees and separates paclitaxel molecules and facilitates their absorption into the wall of the artery.
Invatec plans to launch a randomized trial, the IN.PACT Deep study, in the first half of 2009, to provide additional data about the effectiveness of the new treatment concept.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.